ArticleBrain sciences2021

A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats.

Elina Rubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.